CD4 and Huntington disease: Further analysis showed that TCR-modulated signaling through p-AKT and p-ERK was consistently and significantly lower in PD-1+ as compared to PD-1− T cells, in both CD4 and CD8 T subsets from HD as well as baseline samples from patients (Fig. 2a and b).